These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 176403
21. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation. DeSombre ER, Kledzik G, Marshall S, Meites J. Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195 [Abstract] [Full Text] [Related]
29. Effect of oophorectomy on estrogen receptors in rat mammary tumors induced by 7,12-dimethylbenz (a)anthracene. Tominaga T, Kitamura M, Tei N. Biken J; 1977 Dec; 20(3-4):143-5. PubMed ID: 96813 [No Abstract] [Full Text] [Related]
30. Lack of correlation between the presence of estrogen receptor and histological type of mammary cancer induced by 7,12-dimethylbenz[alpha]anthracene. Nomura Y, Abe Y, Yamagata J, Takenaka K. Gan; 1975 Dec; 66(6):689-91. PubMed ID: 178560 [Abstract] [Full Text] [Related]
31. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors. Tsai TL, Katzenellenbogen BS. Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032 [Abstract] [Full Text] [Related]
32. Prolactin binding to 7,12-dimethylbenz(a)anthracene-induced mammary tumors and liver in diabetic rats. Smith RD, Hilf R, Senior AE. Cancer Res; 1977 Nov; 37(11):4070-4. PubMed ID: 409490 [Abstract] [Full Text] [Related]
34. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors. Rozhin J, Ludwig EH, Corombos J, Odden D, Horwitz JP, Hughes R, Hughes DE, Wilson E, Brooks SC. Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049 [Abstract] [Full Text] [Related]
35. Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomas. Ogreid D, Cho-Chung YS, Ekanger R, Vintermyr O, Haavik J, Døskeland SO. Cancer Res; 1987 May 15; 47(10):2576-82. PubMed ID: 3032409 [Abstract] [Full Text] [Related]
36. Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. Asselin J, Labrie F. J Steroid Biochem; 1978 Nov 15; 9(11):1079-82. PubMed ID: 106188 [No Abstract] [Full Text] [Related]
37. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Kledzik GS, Bradley CJ, Marshall S, Campbell GA, Meites J. Cancer Res; 1976 Sep 15; 36(9 pt.1):3265-8. PubMed ID: 824050 [Abstract] [Full Text] [Related]
38. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction, and its relationship to cyclic AMP-dependent protein kinase. Abou-Issa H, Duruibe VA. Biochem Biophys Res Commun; 1986 Feb 26; 135(1):116-23. PubMed ID: 3006676 [Abstract] [Full Text] [Related]
39. The combined effects of dietary fat and estrogen on survival, 7,12-dimethylbenz(a)anthracene-induced breast cancer and prolactin metabolism in rats. Clinton SK, Li PS, Mulloy AL, Imrey PB, Nandkumar S, Visek WJ. J Nutr; 1995 May 26; 125(5):1192-204. PubMed ID: 7738679 [Abstract] [Full Text] [Related]
40. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors. Kelly PA, Asselin J, Caron MG, Raynaud JP, Labrie F. Cancer Res; 1977 Jan 26; 37(1):76-81. PubMed ID: 187338 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]